Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

40 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Selective binding and oligomerization of the murine granulocyte colony-stimulating factor receptor by a low molecular weight, nonpeptidyl ligand.
Doyle ML, Tian SS, Miller SG, Kessler L, Baker AE, Brigham-Burke MR, Dillon SB, Duffy KJ, Keenan RM, Lehr R, Rosen J, Schneeweis LA, Trill J, Young PR, Luengo JI, Lamb P. Doyle ML, et al. Among authors: trill j. J Biol Chem. 2003 Mar 14;278(11):9426-34. doi: 10.1074/jbc.M209220200. Epub 2003 Jan 10. J Biol Chem. 2003. PMID: 12524421 Free article.
Treating acute exacerbations of COPD with Chinese herbal medicine to aid antibiotic use reduction (Excalibur): a randomised double-blind, placebo-controlled feasibility trial.
Willcox ML, Hu XY, Oliver T, Thorne K, Boxall C, He G, Simpson C, Brotherwood B, O'Neil A, Waugh R, Tilt E, Trill J, Goward N, Francis N, Thomas M, Little P, Wilkinson T, Liu JP, Griffiths G, Moore M. Willcox ML, et al. Among authors: trill j. Front Pharmacol. 2023 Sep 25;14:1221905. doi: 10.3389/fphar.2023.1221905. eCollection 2023. Front Pharmacol. 2023. PMID: 37818189 Free PMC article.
Treating Acute EXacerbations of COPD with Chinese HerbAL MedIcine to aid AntiBiotic Use Reduction (EXCALIBUR): study protocol of a randomised double-blind, placebo-controlled feasibility trial.
Hu XY, Oliver T, Willcox M, Simpson C, Thorne K, Trill J, Francis N, Stuart B, Thomas M, Little P, Liu JP, Griffiths G, Moore M. Hu XY, et al. Among authors: trill j. Pilot Feasibility Stud. 2022 Dec 19;8(1):262. doi: 10.1186/s40814-022-01224-8. Pilot Feasibility Stud. 2022. PMID: 36536462 Free PMC article.
Chinese Patent Medicine Shufeng Jiedu Capsules as an Adjuvant Therapy for Community-Acquired Pneumonia: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
Zhang XW, Xia RY, Gao JQ, Liu JJ, Xu DH, Li X, Hu XY, Willcox M, Moore M, Dai MY, Trill J, Fei YT, Liu JP. Zhang XW, et al. Among authors: trill j. Front Pharmacol. 2022 Jul 4;13:923395. doi: 10.3389/fphar.2022.923395. eCollection 2022. Front Pharmacol. 2022. PMID: 35860018 Free PMC article.
40 results